Annie R. Aubry

Montreal, QC, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Optimization of synthetic human VH affinity and solubility through in vitro affinity maturation and minimal camelization.

Optimization of synthetic human VH affinity and solubility through in vitro affinity maturation and minimal camelization.

Journal: Protein science : a publication of the Protein Society

Published: November 27, 2024

Broadly reactive anti-VHH antibodies for characterizing, blocking, or activating nanobody-based CAR-T cells.

Broadly reactive anti-VHH antibodies for characterizing, blocking, or activating nanobody-based CAR-T cells.

Journal: Antibody therapeutics

Published: November 21, 2024

Cold spells over Greenland during the mid-Pliocene Warm Period.

Cold spells over Greenland during the mid-Pliocene Warm Period.

Journal: Nature communications

Published: May 25, 2024

Discovery and preclinical development of a therapeutically active nanobody-based chimeric antigen receptor targeting human CD22.

Discovery and preclinical development of a therapeutically active nanobody-based chimeric antigen receptor targeting human CD22.

Journal: Molecular therapy. Oncology

Published: September 29, 2023

Comparison of polysaccharide glycoconjugates as candidate vaccines to combat Clostridiodes (Clostridium) difficile.

Comparison of polysaccharide glycoconjugates as candidate vaccines to combat Clostridiodes (Clostridium) difficile.

Journal: Glycoconjugate journal

Published: May 08, 2020

Development and Characterization of Mouse Monoclonal Antibodies Specific for Clostridiodes (Clostridium) difficile Lipoteichoic Acid.

Development and Characterization of Mouse Monoclonal Antibodies Specific for Clostridiodes (Clostridium) difficile Lipoteichoic Acid.

Journal: ACS chemical biology

Published: March 20, 2020

In vitro Production and Immunogenicity of a Clostridium Difficile Spore-Specific BclA3 Glycopeptide Conjugate Vaccine.

In vitro Production and Immunogenicity of a Clostridium Difficile Spore-Specific BclA3 Glycopeptide Conjugate Vaccine.

Journal: Vaccines

Published: January 12, 2020

Investigating the candidacy of the serotype specific rhamnan polysaccharide based glycoconjugates to prevent disease caused by the dental pathogen Streptococcus mutans.

Investigating the candidacy of the serotype specific rhamnan polysaccharide based glycoconjugates to prevent disease caused by the dental pathogen Streptococcus mutans.

Journal: Glycoconjugate journal

Published: June 07, 2017

Structural characterization of wall and lipidated polysaccharides from Clostridium perfringens ATCC 13124.

Structural characterization of wall and lipidated polysaccharides from Clostridium perfringens ATCC 13124.

Journal: Carbohydrate research

Published: May 03, 2017

The Type B Flagellin of Hypervirulent Clostridium difficile Is Modified with Novel Sulfonated Peptidylamido-glycans.

The Type B Flagellin of Hypervirulent Clostridium difficile Is Modified with Novel Sulfonated Peptidylamido-glycans.

Journal: The Journal of biological chemistry

Published: July 20, 2016

Targeting surface-layer proteins with single-domain antibodies: a potential therapeutic approach against Clostridium difficile-associated disease.

Targeting surface-layer proteins with single-domain antibodies: a potential therapeutic approach against Clostridium difficile-associated disease.

Journal: Applied microbiology and biotechnology

Published: February 25, 2015

Small-molecule inhibitors of the pseudaminic acid biosynthetic pathway: targeting motility as a key bacterial virulence factor.

Small-molecule inhibitors of the pseudaminic acid biosynthetic pathway: targeting motility as a key bacterial virulence factor.

Journal: Antimicrobial agents and chemotherapy

Published: October 01, 2014

Showing 1-12 of 16

Last Updated: 09/26/2026